LGND - Esai gets Japanese approval for epilepsy drug using Ligand technology
2024-02-22 17:03:07 ET
More on Ligand Pharmaceuticals
- Johnson & Johnson posts Q4 beat as pharma and MedTech outperform
- FDA approves Ligand's Zelsuvmi for treatment of molluscum
- Seeking Alpha’s Quant Rating on Ligand Pharmaceuticals
- Historical earnings data for Ligand Pharmaceuticals
- Financial information for Ligand Pharmaceuticals